Efthimia T. Leonardi, PhD

*** ******** ******

Massapequa, New York 11758

516-***-****

acql2n@r.postjobfree.com

Professional Experience:

****-*******

President

Lucida Medical Communications

Massapequa, NY

Direction of business strategy and new business development

Dynamic leader of remote teams within and outside the US

Participation in industry-wide meetings to discuss and assess current regulatory guidelines and industry practices

Liaising with clients and internal teams both onsite and remotely to ensure client expectations for deliverables and future strategies are met

Participation in medical-legal review as required

Final approver in planning and development of core medical education deliverables across a broad range of therapeutic areas including CNS, immunology, oncology, medical diagnostic devices

oScientific communication strategies across all stages of product development

oBrand planning and lifecycle management

oStrategic publication planning

oPublication development and execution (abstracts, posters, manuscripts, monographs in peer-reviewed journals and relevant specialty medical conferences)

oPromotional strategies and materials (brochures, slide kits, videos, newsletters)

oDigital and mobile content development and management (iOS and Android apps, web-based programs)

oPatient outreach initiatives (e-newsletters, mobile applications, conference materials)

2009-2010

Editorial Team Leader

Complete Medical Communications

Parsippany, NJ

Scientific team leader across multiple therapeutic areas including oncology (e.g., breast cancer, melanoma, lung cancer), inflammatory diseases (including psoriatic arthritis), major depressive disorder, acute and chronic pain, Parkinson’s disease

Strategic and project management of assigned accounts and projects both in the US and UK while working remotely either from home-based or company offices

oScientific lead for assigned accounts

oSupervision of writers and editorial staff to ensure appropriate project delivery at all stages including resourcing to appropriate levels

Publications (posters abstracts, manuscripts) promotional materials and strategies

oMentoring of new writers

oResponsible for day-to-day management of accounts, as well as organic growth of the business

oLiaising with key opinion leaders

oProject tracking and alignment with budget

oProject tracking and alignment in accordance with client processes, including medical-legal review

Participation in industry-wide meetings to discuss and assess current regulatory guidelines and industry practices

Participation in and development of new business proposals and presentations

2007-2009

Associate Scientific Director

Discovery Chicago

Chicago, IL

Scientific lead in content development and strategic scientific communications across multiple therapeutic areas: obesity, type 2 diabetes, multiple sclerosis, cardiometabolic risk, dermatology, multiple sclerosis, pulmonary infectious disease in cystic fibrosis, cord blood stem cell preservation

oPublication planning

oNational advisory boards

oCompetitive analyses and related strategic scientific communications

oStrategic communications consulting with clients addressing multiple launch scenarios

oPromotional materials (animated videos, monographs, slide decks)

Scientific lead in promotional medical and legal review on behalf of agency

Liaised with key opinion leaders to develop content as needed

Mentoring of new hires and editorial assistants

New business development

2006-2007

Scientific Associate

McMahon Publishing Group

New York, New York

Scientific lead in content development and strategic scientific communications across multiple therapeutic areas: acute and chronic pain conditions (prescription opioids), ADHD, oncology (leukemias)

Partnering with clients and supportive personnel in the planning and execution of

o promotional materials (strategic platforms, slide kits, sales training documents) up to and

ostrategic publications

ospecial reports highlighting professional conference activities in McMahon medical news publications (CNS News, Oncology News, Pain Medicine News)

oregulatory materials (package inserts, target product profile for submission to the Food and Drug Administration)

onational advisory boards

ocontinuing medical education materials (slide kits, telecasts, monographs, digital video presentations)

Planning and development of national conference on psychiatry

Planning and development of national conference on pain management

Mentoring and supervision of new hires

2004-2006

Scientific Associate/Biomedical Writer

Phase Five Communications/Grey Healthcare Group

New York, New York

Scientific medical writing across multiple therapeutic areas

Therapeutic areas include oncology, movement disorders, urinary incontinence, migraine prevention, cell transplantation, epilepsy, hypertension

oDevelopment of scientific content for promotional and CME materials (slide kits, videos) up to and through medical-legal review where appropriate

oDevelopment of publication plans, competitive intelligence documents, gap analyses, competitive assessments

oDevelopment and submission of abstracts and manuscripts

oDevelopment and presentation of new business proposals

o Interviewing of key opinion leaders (medical experts in the field)

oPresentation of products to clients (pharmaceutical companies)

2001-2004

Adjunct Assistant Professor

New York University

Graduate School of Arts and Science

New York, New York

Development and instruction of a graduate course in neuropharmacology (Drugs and the Brain)

Mentorship and supervision of four Master of Science students

Investigation of murine and tissue culture models of movement disorders

Presentation of scientific findings to funding agencies

2000-2004

President

Pelmar Consulting, Inc

Massapequa, New York

Development of scientific content for promotional and CME materials

Development of slide kits, newsletters, abstracts for various clients

Client roster: Phase Five Communications, Sunrise Medical Laboratories, Children’s Neurobiological Solutions (CNS) Foundation

1999-2000

Instructor

The Mount Sinai School of Medicine

New York, New York

Scientific investigation of movement disorders

Lecture presentations at scientific meetings

Development of manuscripts and other publications

Successful applications for external funding of research

Instruction of residents and medical students

Presentation of scientific findings to funding agencies

1995-1999

Postdoctoral Associate

The Mount Sinai School of Medicine

New York, New York

Scientific investigation of movement disorders

Presentation of scientific findings at professional meetings

Development of manuscripts and other publications

Successful applications for external funding of research

Education:

1988-1995

Doctor of Philosophy

New York University

Graduate School of Arts and Sciences

New York, New York

Doctoral degree awarded with distinction

Investigation of the role of serotonin in the neurodegenerative mechanism of substituted amphetamines

Presentation of scientific findings at professional meetings

Instruction of graduate and undergraduate courses

1984-1986

Master of Science

New York University

Graduate School of Arts and Science

New York, New York

Majors: Cell Biology and Neuroscience

1980-1984:

Bachelor of Arts

New York University

College of Arts and Science

New York, New York

Majors: Biology and Classics

Awards:

Research Scientist Award, American Parkinson’s Disease Association (1999-2004)

Research Investigator Award, (co-investigator with C. Mytilineou), Bachmann-Strauss Parkinson’s Disease and Dystonia Foundation (1996-1999)

New York University Graduate Assistant Award (1986, 1988-1995)

New York State Regents Scholarship (1980-1984)

New York University College of Arts and Science Scholarship Award (1980-1984)

Publications:

Leonardi ET, Mytilineou C. Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease. Adv Exp Med Biol. 1998; 446:203-222.

Mytilineou C, Leonardi EK, Radcliffe P, Heinonen EH, Han SK, Werner P, Cohen

G, Olanow CW. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity

induced by glutathione depletion. J Pharmacol Exp Ther. 1998;284:700-706.

Mytilineou C, Radcliffe P, Leonardi EK, Werner P, Olanow CW.

L-deprenyl protects mesencephalic dopamine neurons from glutamate

receptor-mediated toxicity in vitro. J Neurochem. 1997;68:33-339.

Ueda S, Kokotos Leonardi ET, Bell J 3rd, Azmitia EC.

Serotonergic sprouting into transplanted C-6 gliomas is blocked by S-100 beta

antisense gene. Brain Res Mol Brain Res. 1995; 29:365-368.

Leonardi ET, Azmitia EC. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacology. 1994;10:231-238.

Skills:

Working knowledge of ACCME, ICMJE, FDA and PhRMA guidelines. Facility with MSOffice programs (Powerpoint, Excel, Word), strategic platform development, publication planning, mentoring and supervision of colleagues, fluent in French and Greek.

Therapeutic areas:

1)CNS-related indications: attention deficit hyperactivity disorder, pain management, migraine, epilepsy, movement disorders, neurodegenerative disease including Parkinson’s disease, Alzheimer’s disease and multiple sclerosis

2) Immunology (rheumatoid arthritis, psoriatic arthritis, dry eye syndrome)

3)Oncology: breast cancer, nonsmall cell lung carcinoma, melanoma, chronic lymphocytic leukemia

4)Cardiovascular and metabolic conditions: diabetes, hypertension, and obesity;) 4) urology: benign prostatic hyperplasia urinary incontinence

5)Infectious disease

6)Women’s health

Contact this candidate